Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

How to make a move for the Real Madrid star in the January transfer window

Real Madrid broke a deal spanning more than a decade to sign former Atlético Madrid right-back Jesús Fortea, widely considered the most promising full-back in Spanish football in his age category. However, now Los Blancos face an attempt to take their jewel from a familiar enemy: Cesc Fábregas.

The former Barcelona player has signed several players in Spain since becoming Como manager, and Cadena Cope says Fortea is the latest. Fortea currently has a contract until 2026, and Real Madrid hope to renew it, but fear that it will be within the last six months to do so and risk losing him in worse conditions than now. Youngsters Paulo Iago and Nico Paz moved to Como for a fee and Los Blancos retained 50% of their rights, and that could happen again with Fortea.

Fortea has been aiming for the top for a long time, and Real Madrid signed him from Atlético despite a non-aggression pact between the two, causing a breakdown in relations, showing how highly they regard him. However, with no signs of first-team opportunities on the horizon, despite injuries and Trent Alexander-Arnold expected to arrive in the summer, it is logical that Fortea would consider trying his luck elsewhere, even if it is returning to the Real Madrid. first team later.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.